| Literature DB >> 21076068 |
Ichiko Kinjyo1, Scott M Gordon, Andrew M Intlekofer, Kennichi Dowdell, Erin C Mooney, Roberto Caricchio, Stephan A Grupp, David T Teachey, V Koneti Rao, Tullia Lindsten, Steven L Reiner.
Abstract
A hallmark of autoimmune lymphoproliferative syndrome (ALPS), caused by mutation of the Fas death receptor, is massive lymphadenopathy from aberrant expansion of CD4(-)CD8(-) (double-negative [DN]) T cells. Eomesodermin (Eomes) is a member of the T-box family of transcription factors and plays critical roles in effector cell function and memory cell fitness of CD8(+) T lymphocytes. We provide evidence in this study that DN T cells exhibit dysregulated expression of Eomes in humans and mice with ALPS. We also find that T cell-specific deletion of Eomes prevents lymphoid hypertrophy and accumulation of DN T cells in Fas-mutant mice. Although Eomes has critical physiological roles in the function and homeostasis of CD8(+) T cells, overexpression of Eomes appears to enable pathological induction or expansion of unusual CD8-related T cell subsets. Thus, antagonism of Eomes emerges as a therapeutic target for DN T cell ablation in ALPS.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21076068 PMCID: PMC2997140 DOI: 10.4049/jimmunol.1003193
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422